Terumo to buy OrganOx for $1.5B to enter transplant field
OrganOx has the potential to capture a greater share in the liver transplant market, where it competes with TransMedics Group, Needham analyst Mike Matson wrote.
Terumo to buy OrganOx for $1.5B to enter transplant field Read More »
